These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 9068128)
21. Tyrosine hydroxylase cells appearing in the mouse striatum after dopamine denervation are likely to be projection neurones regulated by L-DOPA. Darmopil S; Muñetón-Gómez VC; de Ceballos ML; Bernson M; Moratalla R Eur J Neurosci; 2008 Feb; 27(3):580-92. PubMed ID: 18279311 [TBL] [Abstract][Full Text] [Related]
22. Neurotensin receptors and dopamine transporters: effects of MPTP lesioning and chronic dopaminergic treatments in monkeys. Goulet M; Morissette M; Grondin R; Falardeau P; Bédard PJ; Rostène W; Di Paolo T Synapse; 1999 Jun; 32(3):153-64. PubMed ID: 10340626 [TBL] [Abstract][Full Text] [Related]
23. Loss of D3 receptors in the zitter mutant rat is not reversed by L-dopa treatment. Joyce JN; Der TC; Renish L; Osredkar T; Hagner D; Reploge M; Sakakibara S; Ueda S Exp Neurol; 2004 May; 187(1):178-89. PubMed ID: 15081599 [TBL] [Abstract][Full Text] [Related]
24. Prenatal exposure to methamphetamine in the rat: ontogeny of tyrosine hydroxylase mRNA expression in mesencephalic dopaminergic neurons. Gomes-da-Silva J; Pérez-Rosado A; de Miguel R; Fernández-Ruiz J; Silva MC; Tavares MA Ann N Y Acad Sci; 2002 Jun; 965():68-77. PubMed ID: 12105086 [TBL] [Abstract][Full Text] [Related]
25. Sequential administration of GDNF into the substantia nigra and striatum promotes dopamine neuron survival and axonal sprouting but not striatal reinnervation or functional recovery in the partial 6-OHDA lesion model. Rosenblad C; Kirik D; Björklund A Exp Neurol; 2000 Feb; 161(2):503-16. PubMed ID: 10686072 [TBL] [Abstract][Full Text] [Related]
26. Localization of ionotropic glutamate receptors in caudate-putamen and nucleus accumbens septi of rat brain: comparison of NMDA, AMPA, and kainate receptors. Tarazi FI; Campbell A; Yeghiayan SK; Baldessarini RJ Synapse; 1998 Oct; 30(2):227-35. PubMed ID: 9723793 [TBL] [Abstract][Full Text] [Related]
27. Dopamine cell morphology and glial cell hypertrophy and process branching in the nigrostriatal system after striatal 6-OHDA analyzed by specific sterological tools. Gomide V; Bibancos T; Chadi G Int J Neurosci; 2005 Apr; 115(4):557-82. PubMed ID: 15804725 [TBL] [Abstract][Full Text] [Related]
28. Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat. Kirik D; Rosenblad C; Björklund A Exp Neurol; 1998 Aug; 152(2):259-77. PubMed ID: 9710526 [TBL] [Abstract][Full Text] [Related]
29. Selective sprouting of injured dopaminergic neurons induced by embryonic brain grafts. Dunn-Meynell AA; Levin BE Exp Neurol; 1993 Dec; 124(2):231-41. PubMed ID: 7904567 [TBL] [Abstract][Full Text] [Related]
30. Strain differences in the distribution of dopamine transporter sites in rat brain. Jiao X; Paré WP; Tejani-Butt S Prog Neuropsychopharmacol Biol Psychiatry; 2003 Sep; 27(6):913-9. PubMed ID: 14499307 [TBL] [Abstract][Full Text] [Related]
31. Quantitative analyses of GFRalpha-1 and GFRalpha-2 mRNAs and tyrosine hydroxylase protein in the nigrostriatal system reveal bilateral compensatory changes following unilateral 6-OHDA lesions in the rat. Kozlowski DA; Miljan EA; Bremer EG; Harrod CG; Gerin C; Connor B; George D; Larson B; Bohn MC Brain Res; 2004 Aug; 1016(2):170-81. PubMed ID: 15246853 [TBL] [Abstract][Full Text] [Related]
32. Age-dependent effects of 5,7-dihydroxytryptamine on serotonin transporter in different brain areas in the rat. Kostowski W; Bidziński A; Krzaścik P; Szyndler J; Rok P; Kołomańska P; Wisłowska A; Lehner M; Płaźnik A Pol J Pharmacol; 2004; 56(4):383-9. PubMed ID: 15520491 [TBL] [Abstract][Full Text] [Related]
33. Expression of GAP43 mRNA in normally developing and transplanted neurons from the rat ventral mesencephalon. Clayton GH; Mahalik TJ; Finger TE J Comp Neurol; 1994 Sep; 347(3):470-80. PubMed ID: 7822495 [TBL] [Abstract][Full Text] [Related]
34. Damage to dopamine systems differs between Parkinson's disease and Alzheimer's disease with parkinsonism. Murray AM; Weihmueller FB; Marshall JF; Hurtig HI; Gottleib GL; Joyce JN Ann Neurol; 1995 Mar; 37(3):300-12. PubMed ID: 7695230 [TBL] [Abstract][Full Text] [Related]
35. Cyclosporin A attenuates the decrease in tyrosine hydroxylase immunoreactivity in nigrostriatal dopaminergic neurons and in striatal dopamine content in rats with intrastriatal injection of 6-hydroxydopamine. Matsuura K; Makino H; Ogawa N Exp Neurol; 1997 Aug; 146(2):526-35. PubMed ID: 9270064 [TBL] [Abstract][Full Text] [Related]
36. Environmental enrichment decreases cell surface expression of the dopamine transporter in rat medial prefrontal cortex. Zhu J; Apparsundaram S; Bardo MT; Dwoskin LP J Neurochem; 2005 Jun; 93(6):1434-43. PubMed ID: 15935059 [TBL] [Abstract][Full Text] [Related]
37. Astroglial and microglial activation in the wistar rat ventral tegmental area after a single striatal injection of 6-hydroxydopamine. Rodrigues RW; Gomide VC; Chadi G Int J Neurosci; 2004 Feb; 114(2):197-216. PubMed ID: 14702208 [TBL] [Abstract][Full Text] [Related]
38. Involvement of brain endogenous histamine in the degeneration of dopaminergic neurons in 6-hydroxydopamine-lesioned rats. Liu CQ; Chen Z; Liu FX; Hu DN; Luo JH Neuropharmacology; 2007 Dec; 53(7):832-41. PubMed ID: 17919665 [TBL] [Abstract][Full Text] [Related]
39. Developmental regulation of expression of the D3 dopamine receptor in rat nucleus accumbens and islands of Calleja. Gurevich EV; Himes JW; Joyce JN J Pharmacol Exp Ther; 1999 Apr; 289(1):587-98. PubMed ID: 10087054 [TBL] [Abstract][Full Text] [Related]
40. The effect of forebrain lesions in the neonatal rat: survival of midbrain dopaminergic neurons and the crossed nigrostriatal projection. Jaeger CB; Joh TH; Reis DJ J Comp Neurol; 1983 Jul; 218(1):74-90. PubMed ID: 6886067 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]